$50/month copay for eligible GLP-1s, including Wegovy, Zepbound (KwikPen), and the new oral pill Foundayo (orforglipron)*^ Available to Medicare Part D members who meet certain BMI and health criteria* Program runs July 1, 2026 December 31, 2027^ *For eligible Medicare Part D patients with qualifying GLP-1 medication prescription for weight management
Brown or blue pigmented lesions may be caused by overproduction of melanin in basilar melanosis or in benign nevi and malignant melanomas, which are associated with melanocyte overpopulation
Research indicates that GIP signaling plays a role in lipid metabolism and may help the body partition nutrients more effectively, directing calories toward lean tissue maintenance rather than fat storage
Do you have the flu or just a cold
If Medicare covers them, does it save money on treating obesity-related diseases
Journal of Dermatological Science, 57, 83-89